J05AP57 glecaprevir and pibrentasvir
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05AP Antivirals for treatment of HCV infections
J05AP57 glecaprevir and pibrentasvir
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05AP Antivirals for treatment of HCV infections
J05AP57 glecaprevir and pibrentasvir